Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) FCF Margin: 2011-2025

Historic FCF Margin for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to 3.26%.

  • Aytu Biopharma's FCF Margin rose 355.00% to 4.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.29%, marking a year-over-year increase of 214.00%. This contributed to the annual value of 3.26% for FY2025, which is 63.00% down from last year.
  • Aytu Biopharma's FCF Margin amounted to 3.26% in FY2025, which was down 23.81% from 2.63% recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's FCF Margin ranged from a high of 2.63% in FY2024 and a low of 43.18% during FY2021.
  • In the last 3 years, Aytu Biopharma's FCF Margin had a median value of 3.26% in 2025 and averaged 3.56%.
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 5,960bps in 2021, then crashed by 63bps in 2025.
  • Aytu Biopharma's FCF Margin (MRY) stood at 43.18% in 2021, then surged by 31bps to 29.82% in 2022, then surged by 84bps to 4.78% in 2023, then skyrocketed by 45bps to 2.63% in 2024, then decreased by 24bps to 3.26% in 2025.
  • Its last three reported values are 3.26% in FY2025, 2.63% for FY2024, and 4.78% during FY2023.